溶性内分泌素反映了心肌梗塞患者内皮功能障碍:一项回顾性观察性研究
J Urbankova Rathouska1, J Mrazkova2, C Andrys3
1Department of Biological and Medical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Czech Republic.
International journal of medical sciences
|August 6, 2025
概括
在首次心肌梗塞 (MI) 患者中,可溶性内分泌素 (sENG) 和内分泌素水平升高. 在没有先前心血管治疗的情况下,sENG可能表明心脏病发作患者的内皮功能障碍.
科学领域:
- 心血管医学 心血管医学
- 生物标志物发现发现
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 急性缺血性心脏病是动脉样硬化的严重后果,需要识别新的生物标志物.
- 了解早期心肌梗塞 (MI) 病理生理学对于有效的干预至关重要.
- 现有的脂质样本可能无法完全捕捉首次心脏病发作患者的风险.
研究的目的:
- 为了研究PCSK9,BMP-4,sE-selectin,sENG和Endocan的血水平,与健康对照组相比,在首次心脏病发作的患者中.
- 为了确定前没有心血管疾病史或治疗的MI患者内皮功能障碍的潜在生物标志物.
- 探索生物标志物和临床因素 (如BMI和吸烟状况) 之间的相关性.
主要方法:
- 横截面研究设计涉及79名首次心脏病发作患者和17名年龄相匹配的健康对照.
- 使用ELISA和Luminex技术分析的血生物标记度.
- 在MI患者和对照者之间比较生物标志物水平,脂质概况和临床数据.
主要成果:
- 在MI患者和对照人群之间,PCSK9,BMP-4或sE-selectin水平没有显著差异.
- 在心脏病发作患者中观察到显著更高的可溶性内素 (sENG) 和Endocan的血水平.
- 在MI患者中,高的sENG水平与更高的体重指数 (BMI) 和吸烟状况相关.
结论:
- sENG和Endocan是识别心肌梗塞的潜在生物标志物,特别是在未经治疗的个体中.
- 在首次心脏病发作的情况下,sENG显示为内皮功能障碍的生物标志物.
- 需要进一步的研究来验证这些发现并探索治疗意义.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
334
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
214
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214